In summary, TNC acts as an oncogenic factor by promoting cancer cell proliferation and stemness while inhibiting apoptosis and chemosensitivity to paclitaxel in glioma by modulating PI3K/AKT signaling. This evidence concerns the gene AKT1 and cancer.